BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval

  Regeneron and Sanofi will have to wait until September 2024 for the FDA to decide whether to expand Dupixent’s label to include uncontrolled chronic obstructive pulmonary disease.

  May 31, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Drug Development

  Psychedelic Therapies Could Soon Break Through Against Addiction

  LSD, ketamine, ibogaine and related treatments are moving forward in clinical trials for substance use disorders, including alcohol use disorder and opioid use disorder.

  May 31, 2024

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Amyloid Remains a Key Target in Next-Generation Alzheimer’s Treatments

  While more programs now involve candidates with different targets, experts say anti-amyloid therapies will remain a primary player in treating the memory-robbing disease.

  May 31, 2024

   · 

  6 min read

   · 

  Kate Goodwin